CNBC Stock Blog
- Why You Should Play the Reflation Trade: Stock Picker
- S&P to Hit 1,200 by Year-End: Chief Investor
- 5 Big Bank Stocks Investors Should Consider: Strategists
- My 2010 Home Price Outlook: UBS Analyst
- Why Are Options Piling into Dollar Tree?
- Markets Can Rise 5-10% in the Near-Term: Strategist
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- 9 Stocks That Play Rising Water Costs: Strategists
- Gold Prices Can Double in 3 Years: Portfolio Manager
MOST SHARED
- Wednesday's Economic News Crunch Could Tilt Markets
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- The Social Media Gaming Threat
- NBA D-League On The Rise
- Obama Reiterates Commitment to Boost US-India Ties
- Stifling Anger at Work Can Kill, Survey Finds
- Australia Wheat Exporters Face Challenges: GrainCorp
- Japan Export Rebound Eases Fear of New Recession
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
- AIG Board OKs CEO Pay; Benmosche Agrees to Stay
- Obama Reiterates Commitment to Boost US-India Ties
- FDIC's Bair Cautions on Risks in Bank Break-Up Plan
- Wednesday's Economic News Crunch Could Tilt Markets
- Call Me Crazy: Confessions of a Black Friday Shopper
- 'Very Blah' Christmas Is Coming for UK Retailers
- US Firms Hit by Payroll Taxes at Exactly the Wrong Time
- Citi Mortgage Reveals Something the US Treasury Won't
- In Time for Holidays: More Gloom and Doom on Economy
RSS FEED
Text Size 
CNBC News Associate
Markets opened higher on Wednesday, helped by a positive jobs data. Where should investors be looking right now? Bernard Lirola, fund manager of the Needham Aggressive Growth Fund, shared his favorite stock picks.
Lirola's Recommendations:
Trimble Navigation [TRMB
Loading...
()
]—“They create efficiencies for businesses,” Lirola told CNBC.
“They do it through a combination of equipment and software…It is an efficiency driven company…I’m hoping the stock will gain 50 percent in 2 years.”
Express Scripts [ESRX
Loading...
()
]—“They try to drive the cost of drugs down for corporations and also for government,” he said of the firm.
“We see them doubling their earnings to about $7 a share in 3 years, so we’re very happy to pay just 15 times next year earnings for that growth.”
Gilead Sciences [GILD
Loading...
()
]—“They are the leading viral drug solution company in the world—75 percent of HIV patients in the U.S. are treated with their drugs and only 65 percent in Europe, so there’s growth opportunity there,” he said.
“But [Gilead] is also expanding their research to other lines of viral issues, so I see them being taken over by pharmaceutical companies because anti-viral research is very important. They trade at $43, I hope that they’d be taken out in 2 to 3 years at $75 a share.”
______________________________
Other Market Opinions:
- Stock Picker: Buffett Will Target These Industries Next
- 4 High Dividend Yielding Stocks: Portfolio Manager
- Where to Invest Now: Two Strategists' Views
______________________________
CNBC Data Pages:
______________________________
CNBC Slideshows:
______________________________
______________________________
Disclosures:
No immediate information was available for Lirola or his firm.
______________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes